ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer

BACKGROUND: Reactive oxygen species (ROS)-responsive drug delivery systems (DDSs) are potential tools to minimize the side effects and substantially enhance the therapeutic efficacy of chemotherapy. However, it is challenging to achieve spatially and temporally controllable and accurate drug release...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Hanxi, Lu, Wangxing, Liu, Fan, Zhang, Guoqing, Xie, Feifan, Liu, Wenjie, Wang, Lei, Zhou, Wenhu, Cheng, Zeneng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111982/
https://www.ncbi.nlm.nih.gov/pubmed/33975609
http://dx.doi.org/10.1186/s12951-021-00877-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111982/
https://www.ncbi.nlm.nih.gov/pubmed/33975609
http://dx.doi.org/10.1186/s12951-021-00877-6

Ejemplares similares